Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors.
暂无分享,去创建一个
A. Drilon | C. Sima | M. Kris | C. Azzoli | Gregory Riely | V. Miller | N. Rizvi | A. Varghese | M. Pietanza | L. Krug | H. Yu